Is Inovio Gaining Ground in the Coronavirus Vaccine Race?

Moderna (NASDAQ: MRNA) was the first maker of a vaccine for the novel coronavirus to enter clinical trials, but fellow clinical-stage biotech Inovio Pharmaceuticals (NASDAQ: INO) is close behind. Inovio, during its earnings call this week, said it recently completed enrollment in a phase 1 trial.